Publicly sharing clinical results can trigger a range of regulatory and compliance obligations, especially for companies approa

Several structural shifts are shaping the way capital flows in 2025:

Artificial Intelligence companies continued to post strong valuation premiums at Series A, particularly in sectors like Industr

Seed through Series C deal activity gained ground in Q2 2025, with deal sizes up between 5.5% and 22% and valuations rising by